Botulinum toxin type a for urinary bladder, overactive

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Aug 2022: Trial registered, NCT05512039
  2. 12 May 2023: Trial started, NCT05512039

The trials

NCT05512039: Reduced-dose Botox for Urgency Incontinence Among Elder Females

State
Under way
Phase
Phase 1 and Phase 2
People
376 planned
Started
12 May 2023
Primary completion
1 Sep 2026
Arms
Botox: Low dose
Results
None posted
  1. 23 Aug 2022: Trial registered
  2. 12 May 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as AGN-151607-DP, Bocouture, Botox 50 Unit Injection, Botulinum toxin A, Xeomin, incobotulinumtoxin A.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.